PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS

Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOKHEN KNOLDE, GERKHARD BRAJPOL, FRANTS KHOK, SHTEFAN KHENKE, BERNVARD SHELKENS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JOKHEN KNOLDE
GERKHARD BRAJPOL
FRANTS KHOK
SHTEFAN KHENKE
BERNVARD SHELKENS
description Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I> in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO-, or is a direct bond, have a bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin and bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2056432C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2056432C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2056432C13</originalsourceid><addsrcrecordid>eNrjZLALcA0I8XRxVXBxDfIMcwzxDHMNVnD0c1EI8XD1DFII8IgM9vT38Xf3dHb08YlUcHR2Bqp3dPJxVQh29AkJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRgamZibGRs6GxkQoAQAjKyoI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS</title><source>esp@cenet</source><creator>JOKHEN KNOLDE ; GERKHARD BRAJPOL ; FRANTS KHOK ; SHTEFAN KHENKE ; BERNVARD SHELKENS</creator><creatorcontrib>JOKHEN KNOLDE ; GERKHARD BRAJPOL ; FRANTS KHOK ; SHTEFAN KHENKE ; BERNVARD SHELKENS</creatorcontrib><description>Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I&gt; in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO-, or is a direct bond, have a bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin and bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2056432C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19960320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2056432C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOKHEN KNOLDE</creatorcontrib><creatorcontrib>GERKHARD BRAJPOL</creatorcontrib><creatorcontrib>FRANTS KHOK</creatorcontrib><creatorcontrib>SHTEFAN KHENKE</creatorcontrib><creatorcontrib>BERNVARD SHELKENS</creatorcontrib><title>PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS</title><description>Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I&gt; in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO-, or is a direct bond, have a bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin and bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLALcA0I8XRxVXBxDfIMcwzxDHMNVnD0c1EI8XD1DFII8IgM9vT38Xf3dHb08YlUcHR2Bqp3dPJxVQh29AkJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRgamZibGRs6GxkQoAQAjKyoI</recordid><startdate>19960320</startdate><enddate>19960320</enddate><creator>JOKHEN KNOLDE</creator><creator>GERKHARD BRAJPOL</creator><creator>FRANTS KHOK</creator><creator>SHTEFAN KHENKE</creator><creator>BERNVARD SHELKENS</creator><scope>EVB</scope></search><sort><creationdate>19960320</creationdate><title>PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS</title><author>JOKHEN KNOLDE ; GERKHARD BRAJPOL ; FRANTS KHOK ; SHTEFAN KHENKE ; BERNVARD SHELKENS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2056432C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1996</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JOKHEN KNOLDE</creatorcontrib><creatorcontrib>GERKHARD BRAJPOL</creatorcontrib><creatorcontrib>FRANTS KHOK</creatorcontrib><creatorcontrib>SHTEFAN KHENKE</creatorcontrib><creatorcontrib>BERNVARD SHELKENS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOKHEN KNOLDE</au><au>GERKHARD BRAJPOL</au><au>FRANTS KHOK</au><au>SHTEFAN KHENKE</au><au>BERNVARD SHELKENS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS</title><date>1996-03-20</date><risdate>1996</risdate><abstract>Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I (I&gt; in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulphonyl, cycloalkyl, aryl, arylsulphonyl, heteroaryl or an amino acid, each of which can optionally be substituted, B is a basic amino acid, C is a di- or tripeptide, E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or is a direct bond, G is an amino acid, F' is defined as F, can be -NH-(CH2)2-8 or a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO-, or is a direct bond, have a bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin and bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_RU2056432C1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PEPTIDE DERIVATIVES AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A29%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOKHEN%20KNOLDE&rft.date=1996-03-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2056432C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true